These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 34918668)
1. Prognostic significance of PTOV1 expression in cancers: A protocol for systematic review and meta-analysis. Yang Y; Li N; Tian G Medicine (Baltimore); 2021 Dec; 100(50):e28149. PubMed ID: 34918668 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma. Mazzucchelli R; Scarpelli M; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R Cell Oncol (Dordr); 2013 Feb; 36(1):37-42. PubMed ID: 23132460 [TBL] [Abstract][Full Text] [Related]
3. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer. Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166 [TBL] [Abstract][Full Text] [Related]
5. The role of prostate tumor overexpressed 1 in cancer progression. Cánovas V; Lleonart M; Morote J; Paciucci R Oncotarget; 2017 Feb; 8(7):12451-12471. PubMed ID: 28029646 [TBL] [Abstract][Full Text] [Related]
6. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174 [TBL] [Abstract][Full Text] [Related]
7. Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma. Rausch S; Hennenlotter J; Scharpf M; Teepe K; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T J Cancer Res Clin Oncol; 2016 May; 142(5):937-47. PubMed ID: 26746655 [TBL] [Abstract][Full Text] [Related]
8. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes. Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455 [TBL] [Abstract][Full Text] [Related]
9. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression. Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of E-cadherin expression in prostatic carcinoma: A protocol for systematic review and meta-analysis. Zhang X; Zhang Z; Chen S; Jiang J; Qi R; Mi X; Zhang X; Xi Y; Zheng H; Hua B Medicine (Baltimore); 2020 Apr; 99(15):e19707. PubMed ID: 32282726 [TBL] [Abstract][Full Text] [Related]
11. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer. Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739 [TBL] [Abstract][Full Text] [Related]
12. A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells. Maggio V; Cánovas V; Félix AJ; Gómez V; de Torres I; Semidey ME; Morote J; Noé V; Ciudad CJ; Paciucci R Cancer Lett; 2019 Jun; 452():158-167. PubMed ID: 30922918 [TBL] [Abstract][Full Text] [Related]
13. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1. Marqués N; Sesé M; Cánovas V; Valente F; Bermudo R; de Torres I; Fernández Y; Abasolo I; Fernández PL; Contreras H; Castellón E; Celià-Terrassa T; Méndez R; Ramón Y Cajal S; Thomson TM; Paciucci R Oncogene; 2014 Feb; 33(9):1124-34. PubMed ID: 23455324 [TBL] [Abstract][Full Text] [Related]
14. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits. Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622 [TBL] [Abstract][Full Text] [Related]
15. [Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms]. Allina DO; Andreeva YY; Zavalishina LE; Moskvina LV; Frank GA Arkh Patol; 2016; 78(5):9-14. PubMed ID: 27804940 [TBL] [Abstract][Full Text] [Related]
16. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma. Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486 [TBL] [Abstract][Full Text] [Related]
17. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Benedit P; Paciucci R; Thomson TM; Valeri M; Nadal M; Càceres C; de Torres I; Estivill X; Lozano JJ; Morote J; Reventós J Oncogene; 2001 Mar; 20(12):1455-64. PubMed ID: 11313889 [TBL] [Abstract][Full Text] [Related]
18. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of snail in lung cancer: Protocol for a systematic review. Li M; Zhang X; Hu K; Shi M; Dong G; Li D; Zhang P Medicine (Baltimore); 2018 Jul; 97(28):e11539. PubMed ID: 29995827 [TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis confirms the prognostic and immunological effects of prostate tumor overexpressed-1 in human cancers. Liu F; Li Z; Wan S; Li Y; Ye Z; Li D Curr Cancer Drug Targets; 2023 Mar; ():. PubMed ID: 36927431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]